UPDATE 2-Ariad Pharma CEO Berger to retire in deal with top investor

April 29, 2015 7:35 PM

9 0

April 29 (Reuters) - Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle a proxy battle with its largest shareholder Sarissa Capital Management.

Berger said the company is open to strategic alternatives, according to a tweet by Bloomberg. (bit.ly/1ze71So)

Read more

To category page

Loading...